Evelien Humblet

Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial

Gert Van Assche, Séverine Vermeire, Vera Ballet et al. · Gut · 2011 · 140 citations

Pharmacy, Clinical Sciences, Pharmacotherapy +15

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE study

Annick Moens, C. Janneke van der Woude, Mette Julsgaard et al. · Alimentary Pharmacology & Therapeutics · 2019 · 138 citations · Full text

Medicine, Immunology, Obstetrics +14

Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn’s Disease Who Failed Biologic Therapies: A National Cohort Study

Claire Liefferinckx, Bram Verstockt, Ann Gils et al. · Journal of Crohn s and Colitis · 2019 · 120 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab

Annick Moens, Karen van Hoeve, Evelien Humblet et al. · Journal of Crohn s and Colitis · 2018 · 56 citations · Full text

Medicine, Immunology, Obstetrics +13

Effect of vedolizumab dose intensification on serum drug concentrations and regain of response in inflammatory bowel disease patients with secondary loss of response

An Outtier, Lucas Wauters, Jean‐François Rahier et al. · GastroHep · 2021 · 17 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17